Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea
14/06/2018 12:05
June 14 (Reuters) - Acerus Pharmaceuticals Corporation
ASP.TO :
* ACERUS ANNOUNCES APPROVAL OF NATESTO® IN SOUTH KOREA
* ACERUS PHARMACEUTICALS - HYUNDAI PHARM CO LTD REPORTED
SOUTH
KOREA'S MINISTRY OF FOOD AND DRUG SAFETY APPROVED NATESTO
TREATMENT OF HYPOGONADISM
Source text for Eikon: ID:nBwxMv8fa
Further company coverage: ASP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyundai Pharmaceutical
See all newsS.Korea morning-after pill makers jump as court strikes down abortion law
S.Korean stocks close little changed; won edges lower
Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea
Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm
Brief: Hyundai Pharmaceutical to pay annual cash dividend as 50 won/share